UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Nature communications, 2022-06, Vol.13 (1), p.3449-3449, Article 3449

2022

Volltextzugriff (PDF)

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease

Nature communications, 2022-12, Vol.13 (1), p.7868-18, Article 7868

2022

Volltextzugriff (PDF)

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Frontiers in oncology, 2024-04, Vol.14, p.1394393-1394393

2024

Volltextzugriff (PDF)

Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma

Frontiers in immunology, 2021-02, Vol.12, p.618610-618610

2021

Volltextzugriff (PDF)

Daratumumab combinations for patients with newly diagnosed and relapsed multiple myeloma

The Lancet. Haematology, 2023-10, Vol.10 (10), p.e788-e789

2023

Volltextzugriff (PDF)

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

British journal of haematology, 2020-10, Vol.191 (2), p.194-206

2020

Volltextzugriff (PDF)

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression

British journal of haematology, 2022-03, Vol.196 (6), p.e63-e66

2022

Volltextzugriff (PDF)

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

Clinical cancer research, 2020-07, Vol.26 (13), p.3443-3454

2020

Volltextzugriff (PDF)

A young woman with fever and loss of consciousness

BMJ (Online), 2018-12, p.k4363

2018

Volltextzugriff (PDF)

Interesting case of lymphocytosis and splenomegaly

BMJ (Online), 2016-03, Vol.352, p.i1227

2016

Volltextzugriff (PDF)

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors

British journal of haematology, 2022-02, Vol.196 (3), p.e21-e26

2022

Volltextzugriff (PDF)

DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation

British journal of haematology, 2021-02, Vol.192 (3), p.e73-e77

2021

Volltextzugriff (PDF)

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

British journal of haematology, 2021-05, Vol.193 (4), p.750-760

2021

Volltextzugriff (PDF)

Bruising and abnormal leucocytes on a blood film--a haematological emergency

BMJ (Online), 2017-03, Vol.356, p.j1164

2017

Volltextzugriff (PDF)

Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy

British journal of haematology, 2021-09, Vol.194 (5), p.857-861

2021

Volltextzugriff (PDF)

Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience

Leukemia & lymphoma, 2021-12, Vol.62 (14), p.3544-3547

2021

Volltextzugriff (PDF)

Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations

British journal of haematology, 2020-09, Vol.190 (5), p.e312-e316

2020

Volltextzugriff (PDF)

A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

British journal of haematology, 2019-04, Vol.185 (2), p.350-353

2019

Volltextzugriff (PDF)

Response to ‘Impact of immunosuppression on mortality in critically ill COVID‐19 patients’

British journal of haematology, 2020-11, Vol.191 (3), p.505-506

2020

Volltextzugriff (PDF)

Ascites

British journal of hospital medicine (London, England : 2005), 2015-02, Vol.76 (2), p.C23-C27

2015

Volltextzugriff (PDF)

Co-Operation of MCL-1 and BCL-X L Anti-Apoptotic Proteins in Stromal Protection of MM Cells from Carfilzomib Mediated Cytotoxicity

Blood, 2021-11, Vol.138 (Supplement 1), p.2677-2677

2021

Volltextzugriff (PDF)

Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones

Blood, 2023-11, Vol.142 (Supplement 1), p.1999-1999

2023

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(18)
Life Sciences & Biomedicine
(18)
Hematology
(14)
Female
(11)
Male
(11)
Multiple Myeloma
(10)
Patients
(7)
Aged
(6)
Middle Aged
(6)
Multiple Myeloma - Pathology
(5)
Retrospective Studies
(5)
Adult
(4)
Aged, 80 And Over
(4)
Bone Marrow
(4)
Junior Doctor
(4)
Multiple Myeloma - Therapy
(4)
Oncology
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(34)
Ebook Central Perpetual and DDA
(21)
eBooks on EBSCOhost
(21)
NUS Single-Journal Subscriptions
(21)
Wiley Online Library All Obooks
(21)
MEDLINE
(18)
Journals@Ovid Ovid Full Text
(16)
Wiley Online Library Journals
(10)
Wiley Online Library
(10)
IngentaConnect Journals
(4)
IngentaConnect
(4)
JSTOR
(3)
BMJ
(3)
Nexis Uni
(2)
Nature
(2)
Taylor & Francis Online
(1)
ScienceDirect
(1)
Taylor & Francis Journals Auto-Holdings Collection
(1)
Taylor & Francis
(1)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity

Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma

Daratumumab combinations for patients with newly diagnosed and relapsed multiple myeloma

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

Applying current smouldering myeloma risk models to a UK single‐centre cohort and clinical features at progression

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 + PD-1 + Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

A young woman with fever and loss of consciousness

Interesting case of lymphocytosis and splenomegaly

Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors

DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation

Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study

Bruising and abnormal leucocytes on a blood film--a haematological emergency

Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy

Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience

Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations

Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

Response to ‘Impact of immunosuppression on mortality in critically ill COVID‐19 patients’

Ascites

Co-Operation of MCL-1 and BCL-X L Anti-Apoptotic Proteins in Stromal Protection of MM Cells from Carfilzomib Mediated Cytotoxicity

Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones

Suchergebnisse filtern